So I've been watching Ensign, and there's a pretty solid reason why it's been quietly outperforming the broader market. Their latest earnings actually hit different - beat EPS estimates by 4% with adjusted earnings of $1.82, and the real story is in the operational metrics.

The occupancy numbers are what caught my eye. Same-facility occupancy jumped to 83.8%, up 240 basis points year-over-year. For a healthcare operator, that's the kind of signal that matters because it directly translates to patient days and revenue. Ensign's top line came in at $1.36 billion, up 20.2% YoY, and adjusted net income grew 23.2% - that's the kind of growth trajectory that makes sense why the stock has been grinding higher.

What's interesting is they're managing this growth while keeping expenses in check. Yes, costs went up 19.9% YoY, but they still came in below guidance. Their balance sheet also looks healthier - cash position improved to $503.9 million, long-term debt actually decreased, and total equity is now $2.2 billion. That's the kind of financial flexibility that gives investors confidence.

Looking at their 2026 guidance, Ensign is projecting revenues between $5.77-$5.84 billion and adjusted EPS of $7.41-$7.61. That's meaningful growth from 2025 levels. The skilled nursing segment continues to be the engine - $1.3 billion in quarterly revenue with segment income hitting $169.3 million. Their rental business is also firing on all cylinders with revenue up 37.2% YoY.

Estimates have been trending upward since earnings dropped, which tells you analysts are seeing the same momentum. For a healthcare play in this environment, Ensign's combination of operational improvement and solid financial positioning makes it worth keeping on the radar.